Terlipressin Clinical Trials

3 actively recruiting trials

No change since May 2026

Also known as: carbitocin, glypressin

Top Sponsors

Wael Elbanna Clinic2
Istanbul Medipol University Hospital1

Indications

Myoma2
Cancer2
Liver Disease1
Portal Hypertension1
Liver Transplantation1

Other3 trials

Effects of Terlipressin and Somatostatin on Portal Pressure in Patients Undergoing Living Donor Liver Transplantation

N/A

The Effect of Intracapsular Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations

N/A

The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.